Research indicates that people in need of addiction treatment and their family members are often desperate to find effective treatment but have little credible information to help them sort out the various claims of providers and the wide variety of treatment approaches. To address this problem, RTI is leading the development of a quality measurement […]

Despite its recognized need, substance use disorder service integration remains extremely limited within HIV/AIDS-related settings. This is a problematic issue given that substance use is highly prevalent among individuals living with HIV/AIDS, which makes substance use disorder service integration of high public health relevance. To tackle this challenge, RTI led a study to identify Substance-Treatment-Strategy […]

Assessing treatment outcomes is vital for providers in order to maximize both treatment effectiveness and cost-effectiveness of treatment. To compare the effectiveness of approaches that public substance use disorder systems are using to refer patients to particular addiction treatment settings, RTI assisted providers following the American Society of Addiction Medicine (ASAM) criteria, which were developed […]

Understanding the effectiveness and cost-effectiveness of treatments is vital to maximizing health care quality and driving value. RTI led the first study to estimate the long-term cost-effectiveness of alcohol treatments, which included developing a dynamic patient-level simulation model. RTI applied this approach to the largest pharmacotherapy trial conducted for alcoholism in the United States, the […]

There has been a recognized gap in knowledge about the effectiveness of MAT in real world settings. RTI is conducting a comprehensive, mixed method evaluation to assessed the type of MAT and provider and patient (as well as policy and program) factors that influence the effectiveness of MAT in decreasing overdose death rates and other […]

Cancer is a devastating—yet all-too-common—diagnosis in the United States. Apart from uncertainty around treatment and outcomes, patients must also deal with the uncertainty of the financial burden treatment may pose—”What is my treatment going to cost, and how can I pay for it?” To participate in the Centers for Medicare & Medicaid Services (CMS) Oncology Care […]

The states of Kansas and Missouri are among the 18 states that have opted not to expand Medicaid under the Affordable Care Act. Several foundations that promote a culture of health, help enroll people in health insurance, and support safety-net health care providers in these states shared a sense that people in Kansas and Missouri […]

State purchasing programs require evidence to inform their decision-making. RTI conducted an assessment for the state of Washington to determine which technologies should be included in and covered under the evidence-based purchasing program for the State of Washington Health Care Authority. We conducted the assessment by applying internationally recognized systematic review standards across a broad […]

Developing effective policies for long-term care services and supports (LTSS) requires an understanding of consumer preferences and what consumers are willing to pay for long-term care services. It also enables insurance companies to design long-term care policies that consumers may consider buying. To inform such policies, RTI conducted a national survey of adults regarding their […]

Successful Medicaid expansion requires an understanding of strategies for successful implementation. To inform such strategies, RTI assessed Medicaid expansion in five states. RTI conducted interviews to identify approaches and barriers to enrolling and serving newly eligible populations, impacts of expanded Medicaid coverage on providers that traditionally had high proportions of uninsured patients, and experience of […]